Abstract: The invention relates generally to vaccine compositions that are capable of eliciting and sustaining an immune response in a subject. The vaccine composition comprises a water-in-oil emulsion and a plurality of immunogen loaded hydrogel particles surrounded with a cationic polymer shell dispersed in the aqueous phase of the emulsion.
Type:
Grant
Filed:
March 13, 2019
Date of Patent:
June 7, 2022
Assignee:
CAPSULAR TECHNOLOGIES PTY LTD
Inventors:
David E. Mainwaring, Mohammad Al Kobaisi
Abstract: The invention relates to an injectable composition for rapid and sustained delivery of a biologically active agent and to uses of the injectable composition in the treatment or prevention of a condition in a subject. The injectable composition comprises a water-in-oil emulsion having an aqueous phase dispersed in an oil phase. The aqueous phase comprises a plurality of hydrogel particles and an aqueous liquid and a biologically active agent is contained in the hydrogel particles and in the aqueous liquid.
Type:
Grant
Filed:
April 11, 2017
Date of Patent:
February 2, 2021
Assignee:
CAPSULAR TECHNOLOGIES PTY LTD
Inventors:
Mohammad Al Kobaisi, David E. Mainwaring
Abstract: The invention relates to an injectable composition for rapid and sustained delivery of a biologically active agent and to uses of the injectable composition in the treatment or prevention of a condition in a subject. The injectable composition comprises a water-in-oil emulsion having an aqueous phase dispersed in an oil phase. The aqueous phase comprises a plurality of hydrogel particles and an aqueous liquid and a biologically active agent is contained in the hydrogel particles and in the aqueous liquid.
Type:
Application
Filed:
April 11, 2017
Publication date:
May 2, 2019
Applicant:
CAPSULAR TECHNOLOGIES PTY LTD
Inventors:
Mohammad AL KOBAISI, David E. MAINWARING
© 2026 Justia
